Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study

Basit Öğe Kaydı
dc.contributor.authorKeles, A.
dc.contributor.authorDemirtas, B.
dc.contributor.authorHamid-Zada, I.
dc.contributor.authorKado, A.
dc.contributor.authorIsman, F. K.
dc.contributor.authorYildirim, A.
dc.date.accessioned2025-05-10T19:28:06Z
dc.date.issued2024
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpageS1470
dc.identifier.issn0302-2838
dc.identifier.issn1873-7560
dc.identifier.scopusqualityQ1
dc.identifier.startpageS1468
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7196
dc.identifier.volume85
dc.identifier.wosWOS:001282821401312
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Urology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleAssessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu